{
  "trial_id": "NCT00458731",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "histological confirmation of Solid Tumor or Lymphoma that is metastatic or unresectable",
      "label": "met"
    },
    {
      "criterion": "ECOG performance status =< 2 (Karnofsky >= 60%)",
      "label": "met"
    },
    {
      "criterion": "Leukocytes >= 3,000/mcL",
      "label": "met"
    },
    {
      "criterion": "Absolute neutrophil count >= 1,500/mcL",
      "label": "met"
    },
    {
      "criterion": "Platelets >= 100,000/mcL",
      "label": "met"
    },
    {
      "criterion": "Total bilirubin =< 2.0 mg/dL (does NOT apply to patients with Gilbert's Syndrome)",
      "label": "met"
    },
    {
      "criterion": "AST(SGOT)/ALT(SGPT) =< 2.5 X institutional upper limit of normal",
      "label": "met"
    },
    {
      "criterion": "Serum creatinine =< 2.0 mg/dL",
      "label": "met"
    },
    {
      "criterion": "Patients MUST have recovered from all treatment related toxicities to Grade 1 NCI CTC (v 4.0) in severity",
      "label": "met"
    },
    {
      "criterion": "Patients must be willing and able to review, understand, and provide written consent before starting therapy",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with squamous non-small cell lung carcinoma",
      "label": "triggers"
    },
    {
      "criterion": "Serious or non-healing wound, ulcer or bone fracture",
      "label": "triggers"
    },
    {
      "criterion": "History of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess within 28 days of day 1 of registration",
      "label": "triggers"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00458731",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_test10_top50"
  }
}